Effect of Adding Dexmedetomidine as Adjuvant to Bupivacaine in US Guided ESPB for Post MRM Pain Management
Erector Spinae Plane Block
About this trial
This is an interventional treatment trial for Erector Spinae Plane Block
Eligibility Criteria
Inclusion Criteria: Age:30-65years. Physical status: ASA I,II. BMI<35. Localized breast cancer Exclusion Criteria: Age:<30 and >65 years. Refusal of procedure or participation in the study by the patient. Physical status: ASA III or above. History of allergy to the study drug. BMI>35. Bleeding disorders and coagulopathy. Psychiatric illness that may interfere with the study. Metastatic breast cancer.
Sites / Locations
- Faculty of Medicine Ain Shams UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Patients receiving Block with Bupivacaine only
Patients receiving Block using Bupivacaine with Dexmedetomidine
consists of patients receiving erector spinae plane block with Bupivacaine only
consists of patients receiving erector spinae plane block using bupivacaine with Dexmedetomidine